The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
Macaque model for severe acute respiratory syndrome.
Publication Type
Academic Article
Authors
Rowe T, Gao G, Hogan R, Crystal R, Voss T, Grant R, Bell P, Kobinger G, Wivel N, Wilson J
Journal
J Virol
Volume
78
Issue
20
Pagination
11401-4
Date Published
10/01/2004
ISSN
0022-538X
Keywords
Disease Models, Animal, Severe acute respiratory syndrome-related coronavirus, Severe Acute Respiratory Syndrome
Abstract
Rhesus and cynomolgus macaques were challenged with 10(7) PFU of a clinical isolate of the severe acute respiratory syndrome (SARS) coronavirus. Some of the animals developed a mild self-limited respiratory infection very different from that observed in humans with SARS. The macaque model as it currently exists will have limited utility in the study of SARS and the evaluation of therapies.